Bank of New York Mellon »

Spruce Biosciences shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $366k 6.8k 54.00

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Spruce Biosciences

Ikarian Capital
Millennium Management
Citadel Advisors
ADAR1 Capital Management
Alyeska Investment Group
Wellington Management Company
Boothbay Fund Management
Balyasny Asset Management
Carlyle
Quinn Opportunity Partners
BlackRock
Geode Capital Management
Squadron Capital Management
Diadema Partners
Bank of New York Mellon

View all funds holding Spruce Biosciences